2620
P. M. Fresneda, J. A. Blázquez / Tetrahedron Letters 53 (2012) 2618–2621
chromatographed on a silica gel column using EtOAc/CH2Cl2/n-hexane (2:3:6)
References and notes
as the eluent to give 4a (85% and 30%) or 4b (84% and 25%) yields.
Ethyl N-methoxymethyl-1-(4-methoxyphenyl)-9H-pyrido[3,4-b]indole-3-
carboxylate (4a). Yield 85%, 62 mg, white prisms, mp 167–168 °C (CH2Cl2/n-
hexane, 4:1). 1H NMR (400 MHz, CDCl3, 25 °C): d = 1.47 (t, J = 7.2 Hz, 3H), 2.94
(s, 3H), 3.90 (s, 3H), 4.52 (q, J = 7.2 Hz, 2H), 5.29 (s, 2H), 7.05 (dd, J = 8.8, 2.4 Hz,
2H), 7.40 (td, J = 7.4, 1.2 Hz, 1H), 7.58–7.65 (m, 4 H), 8.22 (d, J = 7.6 Hz, 1H),
8.83 (s, 1H). 13C NMR (100 MHz, CDCl3, 25 °C): d = 14.5, 55.4, 61.6, 74.6, 111.3,
113.9, 116.3, 121.6, 122.1, 129.1, 130.8, 131.1, 131.6, 136.2, 138.5, 142.5, 144.3,
1. For reviews on the chemistry and biology of b-carbolines, see: (a) Love, B. E.
Org. Prep. Proced. Int. 1996, 28, 3–64; (b) Cao, R.; Peng, W.; Wang, Z.; Xu, A. Curr.
Med. Chem. 2007, 14, 479–500; (c) Rosillo, M.; González-Gómez, A.;
Domínguez, G.; Pérez-Castells, J. Targets Heterocycl. Syst.: Chem. Properties
2008, 12, 212–257.
2. (a) Boursereau, Y.; Coldham, I. Bioorg. Med. Chem. Lett. 2004, 14, 5841–5844; (b)
Winkler, J. D.; Londregan, A. T.; Hamann, M. T. Org. Lett. 2006, 8, 2591–2594; (c)
Shilabin, A. G.; Kasanah, N.; Tekwani, B. L.; Hamann, M. T. J. Nat. Prod. 2008, 71,
1218–1221.
3. (a) Chen, Z.; Cao, R.; Shi, B.; Yi, W.; Yu, L.; Song, H.; Ren, Z. Chem. Pharm. Bull.
2010, 58, 901–907; (b) Cao, R.; Guan, X.; Shi, B.; Chen, Z.; Ren, Z. Eur. J. Med.
Chem. 2010, 45, 2503–2515; (c) Chen, Z.; Cao, R.; Shi, B.; Yi, W.; Yu, L.; Song, H.
Bioorg. Med. Chem. Lett. 2010, 20, 3876–3879; (d) Li, S.; Yang, B.; Zhang, Q.;
Zhang, J.; Wang, J.; Wu, W. Nat. Prod. Commun. 2010, 5, 1591–1596.
4. Rook, Y.; Schmidtke, K.; Gaube, F.; Schepmann, D.; Wünch, B.; Heilmann, J.;
Lhemann, J.; Winckler, T. J. Med. Chem. 2010, 53, 3611–3617.
5. (a) Guan, H.; Chen, H.; Peng, W.; Ma, Y.; Cao, R.; Liu, X.; Xu, A. Eur. J. Med. Chem.
2006, 41, 1167–1179; (b) Brahmbhatt, K. G.; Ahmed, N.; Sabde, S.; Mitra, D.
Bioorg. Med. Chem. Lett. 2010, 20, 4416–4419.
6. Tonin, L. T. D.; Panice, M. R.; Nakamura, C. V.; Rocha, K. J. P.; dos Santos, A. O.;
Ueda-Nakamura, T.; da Costa, W. F.; Sarragiotto, M. H. Biomed. Pharmacother.
2010, 64, 386–389.
7. Haarmann-Stemmann, T.; Sendeker, J.; Götz, C.; Krug, N.; Bothe, E.; Fritsche, E.;
Proksch, P.; Abel, J. Arch. Toxicol. 2010, 84, 619–629.
8. (a) Zhang, H.; Larock, R. C. Org. Lett. 2001, 3, 3083–3086; (b) Bonnet, D.;
Ganesan, A. J. Comb. Chem. 2002, 4, 546–548; (c) Kusurkar, R. S.; Goswami, S. K.
Tetrahedron 2004, 60, 5315–5318; (d) Ivanov, I.; Nikolova, S.; Statkova-Abeghe,
S. Heterocycles 2005, 65, 2483–2492; (e) Garcia, M. D.; Wilson, A. J.; Emmerson,
D. P. G.; Jenkis, P. R. Chem. Commun. 2006, 2586–2588; (f) Lee, S.-C.; Choi, S. Y.;
Chung, Y. K.; Park, S. B. Tetrahedron Lett. 2006, 47, 6843–6847; (g) Yeh, W.-P.;
Chang, W. J.; Sun, M.-L.; Sun, C. M. Tetrahedron 2007, 63, 11809–11816; (h)
Omura, K.; Choshi, T.; Wathanabe, S.; Satoh, Y.; Nobuhiro, J.; Hibino, S. Chem.
Pharm. Bull. 2008, 56, 237–238.
160.2, 166.1. IR (nujol):
t
= 1707, 1610, 1456, 1241 cmÀ1. MS (EI): m/z (%): 390
(54), [M]+, 345 (6), [MÀCH2OCH3]+, 283 (7), [MÀPhOCH3]+. Anal. Calcd for
C
23H22N2O4: C, 70.75; H, 5.68, N, 7.17. Found: C, 70.67; H, 5.75; N, 7.23.
Ethyl N-methoxymethyl-1-(4-chlorophenyl)-9H-pyrido[3,4-b]indole-3-
carboxylate (4b). Yield 84%, 62 mg, white prisms, mp 189–191 °C, (CH2Cl2/n-
hexane, 4:1). 1H NMR (400 MHz, CDCl3, 25 °C): d = 1.48 (t, J = 7.2 Hz, 3H), 2.97
(s, 3H), 4.53 (q, J = 7.2 Hz, 2H), 5.24 (s, 2H), 7.42 (t, J = 7.2 Hz, 1H), 7.51 (d,
J = 8.4 Hz, 2H), 7.59 (d, J = 8.0 Hz, 1H), 7.64–7.67 (m, 3H), 8.24 (d, J = 7.6 Hz,
1H), 8.86 (s, 1H). 13C NMR (100 MHz, CDCl3, 25 °C): d = 14.5, 55.4, 61.8, 74.7,
111.2, 116.8, 121.0, 121.9, 122.0, 128.7, 129.9, 130.9, 131.1, 135.1, 135.8, 137.6
138.7, 142.7, 143.1, 165.9. IR (nujol):
t
= 1712, 1458, 1376, 1083 cmÀ1. MS (EI):
m/z (%): 396 (16), [M+2]+, 394 (42), [M]+, 323 (37), [MÀCOOEt]+. Anal. Calcd for
C
22H19ClN2O4: C, 66.92; H, 4.85; Cl, 8.98; N, 7.09. Found: C, 66.89; H, 4.93; Cl,
8.92; N, 7.17.
20. General procedure in ionic liquid/microwave irradiation. Preparation of ethyl 1-
substituted-9H-pyrido[3,4-b]indole-3
carboxylate
(5).
A
mixture
of
or
iminophosphorane (100 mg, 0.19 mmol) and aryl/alkylaldehyde
1
2
arylglyoxal 3 (0.19 mmol) was dissolved in [bmim][BF4] (1 mL), contained in
sealed tube. The reaction mixture was irradiated with single-mode
a
a
microwave (1 W, 200 °C) under nitrogen for 15–20 min. After cooling, the
mixture was extracted with ethyl acetate (10 Â 5 mL) and dried over
anhydrous Na2SO4. To the residual material was added dichloromethane
(10 mL) and active carbon, filtrated over celite, and concentrated to dryness to
give [bmim][BF4], which was re-used. The filtrate was concentrated under
reduced pressure and the residue was chromatographed on a silica gel column
using ethyl acetate/dichloromethane/n-hexane (2:3:6) as the eluent to give 5
in 65–90% yield.
9. Kulkarni, A.; Abid, M.; Török, B.; Huang, X. Tetrahedron Lett. 2009, 50, 1791–
1794.
10. (a) Priebbenow, D. L.; Henderson, L. C.; Pfeffer, F. M.; Stewart, S. G. J. Org. Chem.
2010, 75, 1787–1790; (b) Priebbenow, D. L.; Stewart, S. G.; Pfeffer, F. M. Org.
Biomol. Chem. 2011, 9, 1508–1515.
Ethyl 1-(4-methoxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylate (5a). Yield 79%,
51 mg, white prisms, mp 222–224 °C, (CH2Cl2/n-hexane, 4:1). 1H NMR
(400 MHz, CDCl3, 25 °C): d = 1.48 (t, J = 7.2 Hz, 3H), 3.83 (s, 3H), 4.53 (q,
J = 7.2 Hz, 2H), 6.96 (d, J = 8.8 Hz, 2H), 7.37 (td, 1H), 7.57–7.59 (m, 2H),7.85 (d,
J = 8.8 Hz, 2H), 8.21 (d, J = 8 Hz, 1H), 8.80 (s, 1H), 8.99 (br s, 1H). 13C NMR
(100 MHz, CDCl3, 25 °C): d = 14.5, 55.0, 61.1, 111.5, 114.1, 115.9, 120.6, 121.5,
121.8, 128.3, 129.2, 129.3, 130.0, 134.5, 138.1, 140.1, 142.3, 160.0, 166.0. IR
11. Solé, D.; Bennasar, M.-L.; Jiménez, I. Org. Biomol. Chem. 2011, 9, 4535–4544.
12. (a) Molina, P.; Fresneda, P.; Hurtado, F. Synthesis 1987, 45–48; (b) Molina, P.;
Fresneda, P. J. Chem. Soc., Perkin Trans. 1 1988, 1819–1822; (c) Molina, P.;
Arques, A.; Fresneda, P. M.; Vinader, M. V.; Foces-Foces, M. C.; Hernandez-Cano,
F. Chem. Ber. 1989, 122, 307–313; (d) Molina, P.; Vilaplana, M. J. Synthesis 1994,
1197–1218. and ref. cited therein.
13. Fresneda, P. M.; Molina, P. Synlett 2004, 1–17. and ref. cited therein.
14. (a) de la Hoz, A.; Díaz- Ortíz, A.; Moreno, A. Chem. Soc. Rev. 2005, 34, 164–178;
(b) Kuznetsov, D. V.; Raev, V. A.; Kuranov, G. L.; Arapov, O. V.; Kostikov, R. R.
Russ. J. Org. Chem. 2005, 41, 1757–1787; (c) Polshetiwar, V.; Varma, R. S. Acc.
Chem. Res. 2008, 41, 629–639; (d) Appukkutan, P.; Van der Eycken, E. Eur. J. Org.
Chem. 2008, 1133–1155; (e) Kruithof, A.; Ruijter, R. E.; Orru, R. V. A. Curr. Med.
Chem. 2011, 15, 204–236; (f) Bleda, J. A.; Fresneda, P. M.; Orenes, R.; Molina, P.
Eur. J. Org. Chem. 2009, 2490–2504; (g) Gómez, M. V.; Aranda, A. I.; Moreno, A.;
Cossío, F. P.; de Cózar, A.; Díaz-Ortiz, A.; de la Hoz, A.; Prieto, P. Tetrahedron
2009, 65, 5328–5336; (h) Moral, M.; Ruíz, A.; Moreno, A.; Díaz-Ortiz, A.; López-
Solera, I.; de la Hoz, A.; Sánchez-Migallón, A. Tetrahedron 2010, 66, 121–127; (i)
Kuarm, B. S.; Reddy, Y. T.; Madhav, J. V.; Crooks, P. A.; Rajitha, B. Biorg. Med.
Chem. Lett. 2011, 21, 524–527.
15. (a) Tzschucke, C. C.; Market, C.; Bannwarth, W.; Roller, S.; Hebel, A.; Haag, R.
Angew. Chem., Int. Ed. 2002, 41, 3964–4000; (b) Headley, A. D.; Ni, B. Aldrichim.
Acta 2007, 40, 107–117; (c) Martins, M. A. P.; Frizzo, C. P.; Moreira, D. N.;
Zanatta, N.; Bonacorso, H. G. Chem. Rev. 2008, 108, 2015–2050; (d)Ionic Liquids
in Synthesis; Wasserscheid, P., Welton, T., Eds.; Wiley-VCH: Wheinheim, 2008;
Vols. 1 and 2,. 2nd ed. (e) Candeias, N. R.; Branco, L. C.; Gois, P. M. P.; Afonso, C.
A. M.; Trindade, A. F. Chem. Rev. 2009, 109, 2703–2802; (f) Isambert, N.;
Sánchez-Duque, M. M.; Plaquevent, J-C.; Génisson, Y.; Rodriguez, J.;
Constantieux, T. Chem. Soc. Rev. 2011, 40, 1347–1357; (g) Petkovic, M.;
Seddon, K. R.; Rebelo, L. P. N.; Pereira, C. S. Chem. Soc. Rev. 2011, 40, 1383–1403.
16. Molina, P.; Almendros, P.; Fresneda, P. M. Tetrahedron 1994, 50, 2241–2254.
17. (a) Leadbeater, N. E.; Torenius, H. M. J. Org. Chem. 2002, 67, 3145–3148; (b)
Hoffmann, J.; Nüchter, M.; Ondruschka, B.; Wasserscheid, P. Green Chem. 2003,
5, 296–299; (c) Horikoshi, S.; Hamamura, T.; Kajitani, M.; Yoshizawa-Fujita, M.;
Serpone, N. Org. Process Res. Dev. 2008, 12, 1089–1093; (d) Andriyko, Y. O.;
Reisch, W.; Nauer, G. E. J. Chem. Eng. Data 2009, 54, 855–860.
(nujol):
t
= 3252, 1703, 1458 cmÀ1. MS (EI): m/z (%): 346 (54), [M]+, 345 (6),
283 (7), [MÀPhOCH3]+, 273 (100), [MÀCOOEt]+. Anal. Calcd for C21H18N2O3: C,
72.82; H, 5.24; N, 7.09. Found: C 72.74, H 5.30, N 7.02.
Ethyl 1-(4-methoxybenzoyl)-9H-pyrido[3,4-b]indole-3-carboxylate (5f). Yield
90%, 63 mg, yellow prisms, mp 211 °C (d), (CH2Cl2/n-hexane, 4:1). 1H NMR
(400 MHz, CDCl3, 25 °C): d = 1.54 (t, J = 7.2 Hz, 3H), 3.93 (s, 3H) 4.54 (q,
J = 7.2 Hz, 2H), 7.05 (d, J = 8.8 H, 2H) 7.38–7.42 (m, 1H), 7.60–7.65 (m, 2H), 8.24
(d, J = 7.6 Hz, 1H), 8.83 (d, J = 8.8 Hz, 2H), 9.02 (s, 1H), 10.72 (br s, 1H). 13C NMR
(100 MHz, CDCl3, 25 °C): d = 14.5, 55.6, 61.7, 112.4, 120.3, 121.3, 121.6, 122.1,
129.7, 129.8, 132.0, 134.6, 136.2, 136.5, 138.3, 141.3, 163.7, 165.8, 191.6. IR
(nujol):
t
= 3420,1707, 1596 cmÀ1. MS (EI): m/z (%): 374 (66), [M]+, 315 (58),
[MÀEt]+, 301 (41), [MÀCOOEt]+. Anal. Calcd for C22H18N2O4: C, 70.58; H, 4.85;
N, 7.48. Found: C, 70.50; H, 4.93; N, 7.39.
Ethyl 1-[(1H-indole-3-yl)carbonyl]-9H-pyrido[3,4-b]indole-3-carboxylate (5g).
Yield 76%, 55 mg, yellow prisms, after chromatographed on
a silica gel
column using ethyl acetate/n-hexane/aqueous NH3 (3.5:6:0.5) as the eluent,
and recrystallization from CH2Cl2/n-hexane (4:1), mp 159–161 °C. 1H NMR
(400 MHz, [D6]acetone, 25 °C): d = 1.53 (t, J = 7.2 Hz, 3H), 4.51 (q, J = 7.2 Hz,
2H), 7.25–7.35 (m, 2H), 7.43 (t, J = 7.5 Hz, 1H), 7.58–7.68 (m, 1H), 7.69 (t,
J = 7.5 Hz, 1H), 8.02 (d, J = 8.1 Hz, 1H), 8.45 (d, J = 7.8 Hz, 1H), 8.68 (dd, J = 2.16,
7.7 Hz, 1H), 9.10 (s, 1H), 10.02 (s, 1H), 11.33 (br s, 1H), 11.82 (br s, 1H). 13C
NMR (100 MHz, [D6]acetone, 25 °C): d = 13.5, 60.5, 111.3, 112.8, 116.8, 119.0,
120.6, 120.7, 121.5, 121.8, 121.9, 122.6, 127.6, 128.8, 131.4, 131.5, 135.5, 135.8,
136.5, 138.7, 141.8, 165.0, 186.6. IR (nujol):
t
= 3385, 1697, 1603 cmÀ1. MS
(EI): m/z (%): 383 (87), [M]+, 315 (4), [MÀEt]+, 301 (37), [MÀCOOEt]+. Anal.
Calcd for C23H17N3O3: C, 72.05; H, 4.47; N, 10.96. Found: C, 72.16; H, 4.54; N,
10.88.
21. (a) Moody, C. J.; Ward, J. G. J. Chem. Soc., Perkin Trans. 1 1984, 2895; (b) Molina,
P.; Fresneda, P. M.; García-Zafra, S.; Almendros, P. Tetrahedron Lett. 1994, 35,
8851–8854; (c) Molina, P.; Fresneda, P. M.; García-Zafra, S. Tetrahedron Lett.
1995, 36, 3581–3582; (d) Fresneda, P. M.; Castañeda, M.; Blug, M.; Molina, P.
Synlett 2007, 324–326.
22. (a) Choshi, T.; Kuwada, T.; Fukui, M.; Matsuya, Y.; Sugino, E.; Hibino, S. Chem.
Pharm. Bull. 2000, 48, 108–113; (b) Kuwada, T.; Fukui, M.; Hirayama, M.;
Nobuhiro, J.; Choshi, T.; Hibino, S. Heterocycles 2002, 58, 325–332; (c) Omura,
K.; Choshi, T.; Watanabe, S.; Satoh, Y.; Nobuhiro, J.; Hibino, S. Chem. Pharm. Bull.
2008, 56, 237–238.
23. (a) Meyers, A. I.; Highsmith, T. K.; Buonora, P. T. J. Org. Chem. 1991, 56, 2960–
2964; (b) Zhang, H.; Larock, R. C. J. Org. Chem. 2002, 67, 9318–9330; (c) Putey,
A.; Popowcyz, F.; Do, Q.-T.; Bernard, P.; Talapatra, S. K.; Kozielski, F.; Galmarini,
C. M.; Benoit, J. J. Med. Chem. 2009, 52, 5916–5925; (d) Tohyama, S.; Choshi, T.;
Matsumoto, K.; Yamabuki, A.; Hieda, Y.; Nobuhiro, J.; Hibino, S. Heterocycles
2010, 82, 397–416.
18. Fredlake, C. P.; Crostwaite, J. M.; Gert, D. G.; Aki, S. N. V. K.; Brennecke, J. F. J.
Chem. Eng. Data 2004, 49, 954–964.
19. General procedure in ionic liquids. Preparation of ethyl N-methoxymethyl-1-
substituted-9H-pyrido[3,4-b]indole-3
carboxylate
(4).
A
mixture
of
iminophosphorane 1 (100 mg, 0.19 mmol) and 4-methoxybenzaldehyde 2a,
or 4-chlorobenzaldehyde 2b (0.19 mmol) was dissolved in [bmim][BF4] or
[bmim][PF6] (1 mL), dried previously during 4 h at 80 °C, under nitrogen. The
solution was stirred at 160 °C during 2 h. After cooling, the mixture was
extracted with EtOAc (10 Â 5 mL) and dried over anhydrous Na2SO4. The
solvent was concentrated to dryness under reduced pressure. The residue was